AxoGen

Recent news

• Rating change
  A Quick Look at Today's Ratings for AxoGen(AXGN.US), With a Forecast Between $48 to $55
  Market Newswire · 2026/4/30
• Rating change
  Jefferies Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $50
  Market Newswire · 2026/7/6
• Rating change
  CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $50
  Market Newswire · 2026/5/4
• Rating change
  Raymond James Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $53
  Market Newswire · 2026/9/25
• Rating change
  A Quick Look at Today's Ratings for AxoGen(AXGN.US), With a Forecast Between $50 to $50
  Market Newswire · 2026/4/29
• Rating change
  CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $40
  Market Newswire · 2026/4/17
• Rating change
  Truist Financial Initiates AxoGen(AXGN.US) With Buy Rating, Announces Target Price $60
  Market Newswire · 2026/8/26
• Rating change
  H.C. Wainwright Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $39
  Market Newswire · 2026/2/27
• Truist Financial Maintains AxoGen(AXGN.US) With Buy Rating, Announces Target Price $53
  Market Newswire · 2026/10/1
• Rating change
  CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $45
  Market Newswire · 2026/4/24
• Rating change
  A Quick Look at Today's Ratings for AxoGen(AXGN.US), With a Forecast Between $53 to $55
  Market Newswire · 2026/7/31
• CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $55
  Market Newswire · 2026/10/5
• Rating change
  Lake Street Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $50
  Market Newswire · 2026/4/23
• Truist Financial Maintains AxoGen(AXGN.US) With Buy Rating
  Market Newswire · 2026/9/29
• Wells Fargo Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $48
  Market Newswire · 2026/10/3
• Rating change
  Lake Street Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $50
  Market Newswire · 2026/4/27
• Rating change
  Jefferies Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $55
  Market Newswire · 2026/9/29
• Rating change
  Mizuho Securities Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $40
  Market Newswire · 2026/4/13
• Lake Street Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $55
  Market Newswire · 2026/10/5
• Rating change
  Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), AxoGen (AXGN) and Biohaven Ltd. (BHVN)
  TipRanks · 2026/9/30

Headlines are aggregated automatically and are not independently verified or edited by our team.